tremorine has been researched along with Parkinson Disease, Secondary in 6 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patni, SK | 1 |
| Dandiya, PC | 2 |
| Morrison, AB | 1 |
| Webster, RA | 1 |
| Tasker, RR | 1 |
| Sogabe, K | 1 |
| Kolla, VE | 1 |
| Obvintseva, LM | 1 |
| Nose, T | 1 |
| Kojima, M | 1 |
| Ishida, R | 1 |
| Shintomi, K | 1 |
| Kowa, Y | 1 |
| Bhargava, LP | 1 |
6 other studies available for tremorine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
The influence of monoamine oxidase inhibitors and some other antidepressants on the anti-parkinsonian activity of sub-effective doses of diphenylhydramine in rats and mice.
Topics: Animals; Antidepressive Agents; Catatonia; Diphenhydramine; Humans; Mice; Monoamine Oxidase Inhibito | 1972 |
Drug-induced experimental Parkinsonism.
Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Dr | 1973 |
A rat model for Parkinsonian rest tremor.
Topics: Animals; Cerebellum; Disease Models, Animal; Monoamine Oxidase Inhibitors; Parkinson Disease; Parkin | 1973 |
[Tremorine as test for evaluating antitremor agents (a review of the literature)].
Topics: Animals; Cats; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Guinea P | 1973 |
[Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
Topics: Acetylcholine; Analgesics; Anesthetics, Local; Animals; Anticonvulsants; Barbiturates; Behavior, Ani | 1971 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |